Detalles de la búsqueda
1.
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort.
BMC Infect Dis
; 17(1): 212, 2017 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28298195
2.
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study.
J Antimicrob Chemother
; 71(12): 3519-3527, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27543658
3.
The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort.
BMC Public Health
; 16(1): 878, 2016 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27557878
4.
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study.
J Transl Med
; 13: 89, 2015 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-25886534
5.
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study.
BMC Public Health
; 15: 235, 2015 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25884678
6.
Efficacy and safety of darunavir/ritonavir plus etravirine dual regimen in antiretroviral therapy-experienced patients: a multicenter clinical experience.
HIV Clin Trials
; 15(4): 140-50, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25143023
7.
Genetic analyses of HIV-1 pol sequences from Zimbabwean patients.
New Microbiol
; 37(3): 377-81, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25180853
8.
Vascular graft infections caused by Mycobacterium bovis BCG after BCG immunotherapy for non-muscle-invasive bladder cancer: Case report and review of literature.
J Clin Tuberc Other Mycobact Dis
; 31: 100360, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36941969
9.
Real World Data on Forgiveness to Uncomplete Adherence to Bictegravir/ Emtricitabine/Tenofovir Alafenamide.
J Int Assoc Provid AIDS Care
; 21: 23259582221140208, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36423244
10.
Rilpivirine plus cobicistat-boosted darunavir as alternative to standard three-drug therapy in HIV-infected, virologically suppressed subjects: Final results of the PROBE 2 trial.
Antivir Ther
; 26(3-5): 51-57, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35485333
11.
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia.
PLoS One
; 14(10): e0223181, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31603906
12.
Post-treatment controllers after treatment interruption in chronically HIV-infected patients.
AIDS
; 32(5): 623-628, 2018 03 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29334553
13.
Reduced adherence to antiretroviral therapy is associated with residual low-level viremia.
Pragmat Obs Res
; 8: 91-97, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28603436
14.
NRTI Sparing Therapy in Virologically Controlled HIV-1 Infected Subjects: Results of a Controlled, Randomized Trial (Probe).
J Acquir Immune Defic Syndr
; 72(1): 46-51, 2016 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26910503
15.
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study.
Medicine (Baltimore)
; 95(29): e4091, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27442636
16.
Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation.
Patient Relat Outcome Meas
; 6: 53-60, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25733942
17.
Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter Study.
J Acquir Immune Defic Syndr
; 69(5): 585-92, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26167619
18.
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients.
J Acquir Immune Defic Syndr
; 69(3): 312-8, 2015 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25723139
19.
Switching from an EFV-based STR to a RPV-based STR is effective, safe and improves HIV patients health status.
J Int AIDS Soc
; 17(4 Suppl 3): 19798, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25397542
20.
Early clinical response and presence of viral resistant minority variants: a proof of concept study.
J Int AIDS Soc
; 17(4 Suppl 3): 19759, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25397504